Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
0.713
-0.048 (-6.27%)
At close: Jun 26, 2026, 4:00 PM EDT
0.770
+0.057 (7.93%)
After-hours: Jun 26, 2026, 6:39 PM EDT

Company Description

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People’s Republic of China.

The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine.

It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs.

In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors.

The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Zhengye Biotechnology Holding Limited
Zhengye Biotechnology Holding logo
Country China
Founded 2004
IPO Date Jan 7, 2025
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 269
CEO Songlin Song

Contact Details

Address:
No.1 Lianmeng Road, Jilin Economic & Technical Development Zone
Jilin
China
Phone 86 432 6304 7008
Website jlzybio.com

Stock Details

Ticker Symbol ZYBT
Exchange NASDAQ
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency CNY
IPO Price $4.00
CIK Code 0001975641
CUSIP Number G989MS101
ISIN Number KYG989MS1016
SIC Code 2834

Key Executives

Name Position
Aiden Han Co-Chief Executive Officer
Songlin Song Co-Chief Executive Officer
Ping Wang Chief Financial Officer
Zhongyao Liu Chief Operating Officer
Yuhong Cheng Vice General Manager

Latest SEC Filings

Date Type Title
Jun 4, 2026 6-K Report of foreign issuer
Apr 28, 2026 20-F Annual and transition report of foreign private issuers
Mar 25, 2026 6-K Report of foreign issuer
Mar 2, 2026 6-K Report of foreign issuer
Feb 23, 2026 6-K Report of foreign issuer
Dec 12, 2025 6-K Report of foreign issuer
Oct 22, 2025 144 Filing
Oct 22, 2025 144 Filing
Jul 3, 2025 20-F Annual and transition report of foreign private issuers
May 23, 2025 6-K Report of foreign issuer